Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Connective Tissue Growth Factor (CTGF/CCN2) is a matricellular protein that does not have a single, dedicated receptor. It interacts with several cell surface proteins, including integrins (α5β1, αvβ3), low-density lipoprotein receptor-related proteins (LRPs) like LRP6, heparan sulfate proteoglycans (HSPGs), and TrkA. These interactions regulate cell adhesion, migration, proliferation, angiogenesis, wound healing, skeletal development, and fibrosis. Therapeutic strategies target CTGF itself or its interactions with integrins or LRP6 to modulate pathological processes.
Monoclonal antibodies against CTGF or agents disrupting ligand-receptor interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Connective Tissue Growth Factor Receptor (None).